Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioSig Technologies Inc BSGM

Healthcare Medical Devices
BioSig Technologies, Inc. is a medical technology company focused on deciphering the body’s electrical signals, starting with heart rhythms. The Company’s product, the PURE EP Platform, a non-invasive class II device, provides real-time signal visualization allowing physicians to perform highly targeted cardiac ablation procedures. Integrating with existing systems in the EP lab, PURE EP is... see more

Recent & Breaking News (NDAQ:BSGM)

BioSig Adds Five New Patent Awards to 100+ Total Patent Portfolio Covering Digital Signal Processing Technology and AI

GlobeNewswire November 1, 2023

BioSig AI Sciences Achieves Infrastructure and Technology progress in Development of Generative AI Platform for Hospitals

GlobeNewswire August 24, 2023

BioSig Introduces New Subscription Model for PURE EP(TM) Platform, Offering Quicker Access to Latest Features, Customizations

GlobeNewswire August 23, 2023

BioSig's PURE EP(TM) Platform Debuts New Automated Features in First Patient Cases

GlobeNewswire August 22, 2023

BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications

GlobeNewswire July 25, 2023

BioSig AI Sciences Selected for NVIDIA Inception Partnership Program to Support R&D Collaboration on AI Medical Device Platform for Hospitals

GlobeNewswire July 20, 2023

BioSig Joins Webull Corporate Connect

GlobeNewswire June 29, 2023

BioSig Advances Collaboration on Machine Learning and Artificial Intelligence Solutions for Healthcare

GlobeNewswire June 27, 2023

New Data Out Of Cleveland Clinic Shows BioSig PURE EP May Be Used For More Precise Approach For $6 Billion Annual Atrial Fibrillation Market

Accesswire May 25, 2023

New Data at Heart Rhythm 2023 Suggests that Unipolar Signals May be Used for a More Precise, Accurate Approach to Treating Arrhythmias

GlobeNewswire May 19, 2023

BioSig to Highlight New Data from the PURE EP(TM) Platform at Heart Rhythm 2023

GlobeNewswire May 3, 2023

BioSig Announces New Advisory Board Member Edwin Wang

GlobeNewswire March 27, 2023

BioSig Announces New Advisory Board Member Lorraine Spurge

GlobeNewswire March 24, 2023

BioSig Confirms No Exposure to Silicon Valley Bank

GlobeNewswire March 13, 2023

BioSig Regains Compliance With All Nasdaq Listing Standards

GlobeNewswire February 22, 2023

BioSig Awarded US Patent Claims for its Universal Notch Filter Technology

GlobeNewswire February 17, 2023

BioSig Appoints Former Qorvo CFO as Successor to Steve Chaussy

GlobeNewswire February 7, 2023

BioSig Issues Shareholder Update to Highlight Recent Achievements and Ongoing Developments

GlobeNewswire January 19, 2023

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP(TM) Technology

GlobeNewswire January 10, 2023

Update: BioSig's PURE EP(TM) System Demonstrates Potential Time and Cost Savings at the 15th APHRS Scientific Session in Singapore

GlobeNewswire December 14, 2022